30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

Tissue Regeneration Systems (TRS) entered into an agreement with DePuy Synthes to develop resorbable implants for large bone segmental defect treatment in trauma and orthopaedic oncology, using TRS’ 3-D printing technologies. The agreement includes potential future development of additional applications within DePuy Synthes’ areas of strategic interest. (ResearchViews.com, 6/19/14)